Board – Abzena
Ken Cunningham, Abzena Board Member

Ken Cunningham

Chairman, Abzena plc

Ken Cunningham has over 25 years’ experience in the pharmaceutical industry. He is currently Non-Executive Director of Sunergos Innovations Ltd and Verona Pharma plc. Previously he was Chief Executive Officer of SkyePharma plc and before that he was Chief Executive Officer of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. Earlier in his career he held a variety of clinical development and commercial strategy roles at GlaxoWellcome plc and Warner-Lambert. He holds a Medical Degree from St Mary's, Imperial College, London University.

John Burt, Abzena Board Member

John Burt

Chief Executive Officer, Abzena plc

John joined PolyTherics in November 2010, initially as Chief Business Officer, before becoming CEO in May 2011. Following the acquisition of Antitope and creation of Abzena, he is the Chief Executive Officer of the Group.

In 2004 John co-founded Thiakis, with Professor Sir Steve Bloom (Imperial College), which John led as Chief Executive Officer through to its successful acquisition by Wyeth Pharmaceuticals in December 2008. Previously, John held a range of roles covering finance, technology, licensing and business and corporate development roles with Vanguard Medica plc (now part of Vernalis plc), Glaxo Wellcome plc, GlaxoSmithKline and Imperial Innovations Group plc.

John gained a DPhil (molecular biology) from University of Oxford, following his first degree in Natural Sciences at the University of Cambridge.

Julian Smith, Abzena Board Member

Julian Smith

Chief Financial Officer, Abzena plc

Julian joined PolyTherics as Chief Financial Officer and director in September 2013. He was most recently the Chief Financial and Operations Officer at Imperial Innovations Group plc, where in 2006 he managed its listing on AIM.
Prior to Imperial Innovations Group plc, Julian was the Chief Financial Officer of RadioScape Limited and Group Financial Controller of Mobile Systems International Limited. Julian is a Chartered Accountant and has an MA in engineering science from Oxford University.

Tony Brampton, Abzena Board Member

Tony Brampton

Non-Executive Director, Abzena plc

Partner, Longbow Capital

Tony was previously Managing Director, Corporate Finance at J P Morgan Cazenove, with responsibility for healthcare. During the period 1994-2006 he was actively involved in numerous IPOs, follow on fund raisings, and mergers and acquisitions. He has a BA and MSc in Biochemistry from the University of Oxford. He is a partner at Longbow Capital LLP and a Non-Executive Director of Polar Capital Global Healthcare Growth and Income Trust plc and Domainex Limited.

Nigel Pitchford, Abzena Board Member

Nigel Pitchford

Non-Executive Director, Abzena plc

Chief Investment Officer, Touchstone Innovations plc

Nigel is the Chief Investment Officer for Touchstone Innovations plc, and is responsible for all of the Group’s investment activities. He joined Touchstone Innovations (formerly Imperial Innovations) in January 2012. He was previously a Partner at DFJ Esprit, and prior to that spent 12 years at 3i Group, becoming a Partner in 2006, and ultimately leading the venture team's healthcare activities across Europe and the US.

Nigel sits on the boards of Touchstone Innovations, Veryan Medical and Epsilon 3 Bio. He studied Chemistry at the University of Oxford, before completing a PhD at the University of Durham.

Peter Grant, Abzena Board Member

Peter Grant

Non-Executive Director, Abzena plc

Peter was Chief Executive Officer of Skyepharma PLC from January 2012 to June 2016, when the company merged with Vectura Group plc. He joined Skyepharma as Chief Financial Officer in November 2006.

Previously Peter was Interim Chief Executive Officer of Voice Commerce Group, Group Finance Director at Eurodis Electron plc, Chief Financial Officer at WorldPay plc and Group Finance Director then Group Chief Executive at Molins plc. Prior to this Peter held a variety of senior commercial, financial and general management roles in the General Electric Company plc group of companies. He was previously a Non-Executive Director of ShipServ, Inc. He holds an MA in Mathematics from the University of Oxford and is a Chartered Accountant.

Interested in our services? Get In Touch